D. E. Shaw & Co., Inc. Penumbra Inc Call Options Transaction History

D. E. Shaw & Co., Inc.

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$163.64 - $210.12 $229,095 - $294,168	1,400 Added 11.86%	13,200 $2.56 Million
Q2 2024 Aug 14, 2024	SELL	$172.27 - $223.95 $6.13 Million - $7.97 Million	-35,600 Reduced 75.11%	11,800 $2.12 Million
Q1 2024 May 15, 2024	SELL	$220.09 - $273.15 $4.4 Million - $5.46 Million	-20,000 Reduced 29.67%	47,400 $10.6 Million
Q4 2023 Feb 14, 2024	SELL	$181.44 - $260.22 $5.7 Million - $8.17 Million	-31,400 Reduced 31.78%	67,400 $17 Million
Q3 2023 Nov 14, 2023	BUY	$240.69 - $338.77 $5.2 Million - $7.32 Million	21,600 Added 27.98%	98,800 $23.9 Million
Q2 2023 Aug 14, 2023	BUY	$271.54 - $344.06 $7.01 Million - $8.88 Million	25,800 Added 50.19%	77,200 $26.6 Million
Q1 2023 May 15, 2023	BUY	$220.43 - $278.69 $9.13 Million - $11.5 Million	41,400 Added 414.0%	51,400 $14.3 Million
Q4 2022 Feb 14, 2023	BUY	$151.88 - $228.5 $1.52 Million - $2.29 Million	10,000 New	10,000 $2.22 Million
Q3 2021 Nov 15, 2021	SELL	$250.72 - $291.24 $13.9 Million - $16.2 Million	-55,600 Reduced 84.76%	10,000 $2.67 Million
Q1 2021 May 17, 2021	BUY	$175.6 - $291.43 $9.76 Million - $16.2 Million	55,600 Added 556.0%	65,600 $17.8 Million
Q4 2020 Feb 16, 2021	SELL	$174.98 - $272.83 $874,900 - $1.36 Million	-5,000 Reduced 33.33%	10,000 $1.75 Million
Q2 2018 Aug 14, 2018	BUY	$112.2 - $165.95 $1.68 Million - $2.49 Million	15,000 New	15,000 $2.07 Million

374

29.2M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.37B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.